US equities |
NVDA $236.51 ▲+2.45% MU $1,083.46 ▼-1.27% TSLA $371.69 ▲+4.96% SPCX $157.23 ▲+6.19% SNDK $1,739.33 ▼-2.71% AMD $634.76 ▲+3.09% STX $825.90 ▼-12.66% WDC $406.33 ▼-12.16%
FinancialContent

Medicure Inc (OP:MCUJF)

2.000 -0.020 (-0.99%)
Delayed Quote Updated: 11:37 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Medicure Inc

< Previous 1 2 Next >
News headline image
Medicure Announces Grant of Stock Options
From Medicure, Inc.
Via ACCESS Newswire
News headline image
Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
From Medicure, Inc.
Via ACCESS Newswire
News headline image
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
From Medicure, Inc.
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
From Medicure, Inc.
Via ACCESS Newswire
News headline image
Medicure Announces CFO Change
From Medicure, Inc.
Via ACCESS Newswire
News headline image
Medicure Announces AGM Results and Appointment of New Director
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Via ACCESS Newswire
News headline image
Medicure Announces Resignation of President and Chief Operating Officer
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended September 30, 2025
Via ACCESS Newswire
News headline image
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended June 30, 2025
Via ACCESS Newswire
News headline image
Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025
Via ACCESS Newswire
News headline image
Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
Via ACCESS Newswire
News headline image
Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024
Via ACCESS Newswire
News headline image
Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy
Via ACCESS Newswire
News headline image
Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
Via ACCESS Newswire
News headline image
Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results For Quarter Ended September 30, 2024
Via ACCESSWIRE
News headline image
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Via ACCESSWIRE
News headline image
Medicure Announces Positive Settlement of Product Development and Supply Contracts
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter Ended June 30, 2024
Via ACCESSWIRE
News headline image
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Via ACCESSWIRE
News headline image
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Via ACCESSWIRE
News headline image
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
Via ACCESSWIRE
News headline image
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
Via ACCESSWIRE
< Previous 1 2 Next >